Free Trial

Syros Pharmaceuticals (SYRS) Insider Trading & Ownership

Syros Pharmaceuticals logo
$0.0002 0.00 (0.00%)
As of 05/14/2026 02:42 PM Eastern

Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.26%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$4.21M
Number Of
Insiders Selling
(Last 3 Years)
4
Amount Of
Insider Selling
(Last 3 Years)
$281.76K
Get SYRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Syros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SYRS Insider Buying and Selling by Quarter

Syros Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2024
Nancy A Simonian
Director
Sell37,070$0.27$10,008.90  
11/25/2024
Nancy A Simonian
Director
Sell134,713$0.27$36,372.51  
9/12/2024
Jason Haas
CFO
Buy45,344$1.68$76,177.92  
9/10/2024
Conley Chee
CEO
Buy50,000$1.51$75,500.00  
9/10/2024
Jason Haas
CFO
Buy35,363$1.55$54,812.65  
6/28/2024
Richard A Young
Director
Sell34,837$5.12$178,365.44  
4/2/2024
David Roth
Insider
Sell150$4.98$747.00  
12/21/2023
Srinivas Akkaraju
Director
Buy904,977$4.42$3,999,998.34  
12/6/2023
David Roth
Insider
Sell6,287$3.95$24,833.65  
7/31/2023
David Roth
Insider
Sell7,348$3.95$29,024.60  
7/17/2023Sell689$3.50$2,411.50  
(Data available from 1/1/2013 forward)

SYRS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Syros Pharmaceuticals includes Conley Chee, David Roth, Eric R Olson, Jason Haas, Nancy A Simonian, Richard A Young, and Srinivas Akkaraju. Learn more on insiders at SYRS.

12.26% of Syros Pharmaceuticals stock is owned by insiders. Learn more on SYRS's insider holdings.

The following insiders have purchased SYRS shares in the last 24 months: Conley Chee ($75,500.00), and Jason Haas ($130,990.57).

Insiders have purchased a total of 130,707 SYRS shares in the last 24 months for a total of $206,490.57 bought.

The following insiders have sold SYRS shares in the last 24 months: Nancy A Simonian ($46,381.41), and Richard A Young ($178,365.44).

Insiders have sold a total of 206,620 Syros Pharmaceuticals shares in the last 24 months for a total of $224,746.85 sold.

Syros Pharmaceuticals Active Insiders



This page (NASDAQ:SYRS) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners